1. Search Result
Search Result
Results for "

2102192-68-5

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P99115
    Envafolimab

    ASC 22; KN 035

    PD-1/PD-L1 Cancer
    Envafolimab (ASC 22; KN 035) is a recombinant protein of a humanized single-domain anti- PD-L1 antibody. Envafolimab is created by a fusion of the of anti-PD-L1 domain with Fc fragment of human IgG1 antibody. Envafolimab blocks interaction between PD-L1 and PD-1 with an IC50 value of 5.25 nm. Envafolimab shows antitumor activity. Envafolimab has the potential for the research of solid tumors.